Skip to main content
Log in

Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

This study measured the concentrations of ondansetron in plasma and cerebrospinal fluid (CSF) in six volunteers after oral dosing to steady state. Ondansetron concentrations ranged from 39.5–147 ng ml−1 in plasma and from 2.6–15.4 ng ml−1 in CSF. There was good correlation between plasma and CSF concentrations (r=0.89,p=0.017). CSF concentrations were less than 15% of plasma concentrations in all cases, indicating that the rate of penetration of the blood brain barrier by ondansetron is low.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Colthup PV, Palmer JL (1989) The determination in plasma and pharmacokinetics of ondansetron. Eur J Cancer Clin Oncol 25 [Suppl 1]:S71–74

    Google Scholar 

  • Colthup PV, Felgate CC, Palmer JL, Scully NL (1991) Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly. J Pharm Sci 80 [9]:868–871

    Google Scholar 

  • Hainsworth J, Harvey W, Pendergrass K, Kasimis B, Oblon D, Monoghan G, Gandara D, Hesketh P, Khojasten A, Harker G, York M, Siddique T, Finn A (1991) A single blind comparison of intravenous ondansetron a selective serotonin antagonist with intravenous metoclopramide in the prevention of nausea and vomiting associated with high dose cisplatin chemotherapy. J Clin Oncol 9 [5]:721–728

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simpson, K.H., Murphy, P., Colthup, P.V. et al. Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers. Psychopharmacology 109, 497–498 (1992). https://doi.org/10.1007/BF02247730

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02247730

Key words

Navigation